ClinVar Miner

Submissions for variant NM_000245.4(MET):c.1570C>G (p.Gln524Glu)

dbSNP: rs2116834835
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002049896 SCV002115841 uncertain significance Renal cell carcinoma 2021-08-02 criteria provided, single submitter clinical testing This sequence change replaces glutamine with glutamic acid at codon 524 of the MET protein (p.Gln524Glu). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and glutamic acid. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with MET-related conditions.
Ambry Genetics RCV002397767 SCV002704069 uncertain significance Hereditary cancer-predisposing syndrome 2022-02-04 criteria provided, single submitter clinical testing The p.Q524E variant (also known as c.1570C>G), located in coding exon 4 of the MET gene, results from a C to G substitution at nucleotide position 1570. The glutamine at codon 524 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GeneDx RCV003320850 SCV004025690 uncertain significance not provided 2023-02-09 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.